KRYS
Krystal Biotech Inc.
Company Overview
| Mkt Cap | $5.49B | Price | $197.51 |
| Volume | 595.01K | Change | +4.46% |
| P/E Ratio | 61.6 | Open | $187.68 |
| Revenue | $290.5M | Prev Close | $189.08 |
| Net Income | $89.2M | 52W Range | $122.80 - $207.84 |
| Div Yield | N/A | Target | $218.10 |
| Overall | 66 | Value | 50 |
| Quality | -- | Technical | 83 |
No chart data available
Stock Overview
Updated DailyKrystal Biotech Inc. (KRYS) is a leading Healthcare company in the Biotechnology industry, currently trading at $197.51 with a market capitalization of $5.49 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows KRYS with a volume of 595K shares. The stock opened down 0.74% from yesterday's close of $189.08. Current analyst estimates project earnings of $4.93 per share for this year, with next year targeting $8.67.
KRYS demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for KRYS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 10.4%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 04:48 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRYS | $197.51 | +4.5% | 595.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |